• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE Back to Search Results
Catalog Number SGC0705
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arrhythmia (1721); Bradycardia (1751); Low Blood Pressure/ Hypotension (1914); Perforation (2001)
Event Date 12/17/2021
Event Type  Injury  
Manufacturer Narrative
The customer reported the device is not returning.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This will be filed to report after steerable guide catheter was placed, the patient experienced hypotension, bradycardia requiring medical intervention.It was reported that this was a mitraclip procedure to treat functional mitral regurgitation (mr) with grade 4+.After the steerable guide catheter (sgc) was inserted into the left atrium, aspiration was performed as the dilator and guide wire were removed.The patient had a sudden drop in blood pressure, bradycardia, sinus arrest [arrhythmia] and a smoke like observation [atrial perforation] in echocardiogram was seen in the left atrium.The patient hemodynamics were impaired.Intra-aortic balloon pump (iabp) and a catheter pacing were placed.Anesthesia management was performed stabilizing hemodynamics.Then, the clip delivery system (cds) was advanced to the mitral valve and the clip was safely deployed, reducing mr to 1+.The procedure was completed with stable hemodynamics.In the physician¿s opinion, the hemodynamic impairment was due to 30 cc of blood that was pulled out from the left atrium during aspiration.No additional information was provided.
 
Manufacturer Narrative
The customer reported the device is not returning.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This will be filed to report after steerable guide catheter was placed, the patient experienced hypotension, bradycardia requiring medical intervention.It was reported that this was a mitraclip procedure to treat functional mitral regurgitation (mr) with grade 4+.After the steerable guide catheter (sgc) was inserted into the left atrium, aspiration was performed as the dilator and guide wire were removed.The patient had a sudden drop in blood pressure, bradycardia, sinus arrest [arrhythmia] and a smoke like observation [atrial perforation] in echocardiogram was seen in the left atrium.The patient hemodynamics were impaired.Intra-aortic balloon pump (iabp) and a catheter pacing were placed.Anesthesia management was performed stabilizing hemodynamics.Then, the clip delivery system (cds) was advanced to the mitral valve and the clip was safely deployed, reducing mr to 1+.The procedure was completed with stable hemodynamics.In the physician¿s opinion, the hemodynamic impairment was due to 30 cc of blood that was pulled out from the left atrium during aspiration.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, the reported arrhythmia was due to procedural conditions.The reported bradycardia and hypotension appear to be cascading effects of the arrhythmia.The reported patient effects of arrhythmia and hypotension as listed in the mitraclip system instructions for use are known possible complications associated with mitraclip procedures.The reported unexpected medical intervention and medication required were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design or labeling.H6.Health effect - clinical code 2001 removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G4 STEERABLE GUIDING CATHETER
Type of Device
CATHETER, STEERABLE
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13212362
MDR Text Key285504715
Report Number2024168-2022-00326
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K190167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/10/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/21/2022
Device Catalogue NumberSGC0705
Device Lot Number10622R157
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/26/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/22/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age81 YR
Patient SexMale
Patient Weight58 KG
-
-